Spurney R F, Middleton J P, Raymond J R, Coffman T M
Department of Medicine, Duke University, Durham, North Carolina.
Am J Physiol. 1994 Sep;267(3 Pt 2):F467-78. doi: 10.1152/ajprenal.1994.267.3.F467.
Rat glomerular mesangial cells were used to investigate mechanisms of thromboxane A2 (TxA2) receptor regulation in the kidney. Exposure of mesangial cells to the TxA2 agonist U-46619 for 10 min reduced subsequent TxA2-induced increases in inositol phosphates and intracellular Ca2+ levels by approximately 70%. This loss of receptor responsiveness could be blocked by the TxA2 receptor antagonist SQ-29548 and was reversible after removal of agonist from the incubation medium. Radioligand binding studies using the TxA2 agonist [125I]BOP suggested that exposure of mesangial cells to U-46619 for 10 min reduced TxA2 receptor responsiveness without a loss of receptor sites from plasma membrane fractions of the cell, although the density of mesangial cell TxA2 receptors was decreased by approximately 60% after more prolonged exposure of mesangial cells to thromboxane agonists. Both desensitization to U-46619 and loss of TxA2 binding sites could be attenuated by the protein kinase C (PKC) inhibitors staurosporine, sphingosine, or H-7, and TxA2 receptor responsiveness was reduced in cells incubated with phorbol esters before stimulation with thromboxane agonists. We conclude that 1) agonist-specific decreases in TxA2 receptor responsiveness may involve initial uncoupling of the receptor from its effector systems, followed by a loss of TxA2 receptor sites from plasma membrane fractions of the cell, and 2) PKC may be involved in these processes.
采用大鼠肾小球系膜细胞研究肾脏中血栓素A2(TxA2)受体的调节机制。将系膜细胞暴露于TxA2激动剂U - 46619 10分钟后,随后TxA2诱导的肌醇磷酸和细胞内Ca2 +水平升高降低了约70%。这种受体反应性的丧失可被TxA2受体拮抗剂SQ - 29548阻断,并且在从孵育培养基中去除激动剂后是可逆的。使用TxA2激动剂[125I]BOP进行的放射性配体结合研究表明,将系膜细胞暴露于U - 46619 10分钟可降低TxA2受体反应性,而细胞的质膜部分并未丢失受体位点,尽管系膜细胞长时间暴露于血栓素激动剂后,系膜细胞TxA2受体的密度降低了约60%。对U - 46619的脱敏和TxA2结合位点的丧失均可被蛋白激酶C(PKC)抑制剂星形孢菌素、鞘氨醇或H - 7减弱,并且在用血栓素激动剂刺激之前,用佛波酯孵育的细胞中TxA2受体反应性降低。我们得出结论:1)TxA2受体反应性的激动剂特异性降低可能涉及受体与其效应系统的初始解偶联,随后细胞的质膜部分丢失TxA2受体位点;2)PKC可能参与这些过程。